CNBC
US · 15 hrs ago
✦ 78◉ Centre
AstraZeneca CEO says AI is reshaping drug development — and helping boost the odds of success
78Quality
0Ratings
0Comments
AI Analysis
Quality 78/100
Partisan intensity 35/100
ObjectivePartisan
◉ Centre ✓ Fair headline
AstraZeneca's CEO discusses how artificial intelligence is accelerating drug development and improving success rates in the company's research processes.
AstraZeneca CEO says AI is reshaping drug development — and helping boost the odds of success
AstraZeneca CEO Pascal Soriot said AI is helping the company develop medicines faster and make smarter decisions throughout the research process.
Discussion 0 comments
Sort:
?
No comments yet — be the first to start the discussion!